 |
Previous Article | Next Article 
The Journal of Neuroscience, June 1, 2001, 21(11):3740-3748
Protective Autoimmunity Is a Physiological Response to CNS
Trauma
Eti
Yoles1,
Ehud
Hauben1,
Orna
Palgi3,
Evgenia
Agranov1,
Amalia
Gothilf1,
Avi
Cohen3,
Vijay
Kuchroo4,
Irun R.
Cohen2,
Howard
Weiner4, and
Michal
Schwartz1
Departments of 1 Neurobiology and
2 Immunology, The Weizmann Institute of Science, 76100 Rehovot, Israel, 3 Proneuron Ltd., Industrial Park,
Ness-Ziona, Israel, and 4 Center for Neurologic Diseases,
Harvard Medical School, Brigham and Women's Hospital, Boston,
Massachusetts 02115
Primary damage caused by injury to the CNS is often followed by
delayed degeneration of initially spared neurons. Studies in our
laboratory have shown that active or passive immunization with CNS
myelin-associated self-antigens can reduce this secondary loss. Here we
show, using four experimental paradigms in rodents, that CNS trauma
spontaneously evokes a beneficial T cell-dependent immune response,
which reduces neuronal loss. (1) Survival of retinal ganglion cells in
rats was significantly higher when optic nerve injury was preceded by
an unrelated CNS (spinal cord) injury. (2) Locomotor activity of rat
hindlimbs (measured in an open field using a locomotor rating scale)
after contusive injury of the spinal cord (T8) was significantly better
(by three to four score grades) after passive transfer of myelin basic
protein (MBP)-activated splenocytes derived from spinally injured rats
than in untreated injured control rats or rats similarly treated with
splenocytes from naive animals or with splenocytes from spinally
injured rats activated ex vivo with ovalbumin or without
any ex vivo activation. (3) Neuronal survival after
optic nerve injury was 40% lower in adult rats devoid of mature T
cells (caused by thymectomy at birth) than in normal rats. (4) Retinal
ganglion cell survival after optic nerve injury was higher (119 ± 3.7%) in transgenic mice overexpressing a T cell receptor (TcR) for
MBP and lower (85 ± 1.3%) in mice overexpressing a T cell
receptor for the non-self antigen ovalbumin than in matched wild types.
Taken together, the results imply that CNS injury evokes a T
cell-dependent neuroprotective response.
Key words:
protective autoimmunity; CNS injury; spinal cord injury; optic nerve injury; neuroprotection; degeneration; encephalitogenic T
cells
Copyright © 2001 Society for Neuroscience 0270-6474/01/21113740-09$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
S. K. Garg, R. Banerjee, and J. Kipnis
Neuroprotective Immunity: T Cell-Derived Glutamate Endows Astrocytes with a Neuroprotective Phenotype
J. Immunol.,
March 15, 2008;
180(6):
3866 - 3873.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rossignol, M. Schwab, M. Schwartz, and M. G. Fehlings
Spinal Cord Injury: Time to Move?
J. Neurosci.,
October 31, 2007;
27(44):
11782 - 11792.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Shechter, Y. Ziv, and M. Schwartz
New GABAergic Interneurons Supported by Myelin-Specific T Cells Are Formed in Intact Adult Spinal Cord
Stem Cells,
September 1, 2007;
25(9):
2277 - 2282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Hohlfeld, M. Kerschensteiner, and E. Meinl
Dual role of inflammation in CNS disease
Neurology,
May 29, 2007;
68(22_suppl_3):
S58 - S63.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ziv, H. Avidan, S. Pluchino, G. Martino, and M. Schwartz
Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury
PNAS,
August 29, 2006;
103(35):
13174 - 13179.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Monsonego, J. Imitola, S. Petrovic, V. Zota, A. Nemirovsky, R. Baron, Y. Fisher, T. Owens, and H. L. Weiner
Abeta-induced meningoencephalitis is IFN-{gamma}-dependent and is associated with T cell-dependent clearance of Abeta in a mouse model of Alzheimer's disease
PNAS,
March 28, 2006;
103(13):
5048 - 5053.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kipnis, H. Avidan, R. R. Caspi, and M. Schwartz
Dual effect of CD4+CD25+ regulatory T cells in neurodegeneration: A dialogue with microglia
PNAS,
October 5, 2004;
101(suppl_2):
14663 - 14669.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. POZO and M. DELGADO
The many faces of VIP in neuroimmunology: a cytokine rather a neuropeptide?
FASEB J,
September 1, 2004;
18(12):
1325 - 1334.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kipnis, M. Cardon, H. Avidan, G. M. Lewitus, S. Mordechay, A. Rolls, Y. Shani, and M. Schwartz
Dopamine, through the Extracellular Signal-Regulated Kinase Pathway, Downregulates CD4+CD25+ Regulatory T-Cell Activity: Implications for Neurodegeneration
J. Neurosci.,
July 7, 2004;
24(27):
6133 - 6143.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kipnis, H. Cohen, M. Cardon, Y. Ziv, and M. Schwartz
T cell deficiency leads to cognitive dysfunction: Implications for therapeutic vaccination for schizophrenia and other psychiatric conditions
PNAS,
May 25, 2004;
101(21):
8180 - 8185.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. B. Jones, D. P. Ankeny, Z. Guan, V. McGaughy, L. C. Fisher, D. M. Basso, and P. G. Popovich
Passive or Active Immunization with Myelin Basic Protein Impairs Neurological Function and Exacerbates Neuropathology after Spinal Cord Injury in Rats
J. Neurosci.,
April 14, 2004;
24(15):
3752 - 3761.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Frenkel, Z. Huang, R. Maron, D. N. Koldzic, W. W. Hancock, M. A. Moskowitz, and H. L. Weiner
Nasal Vaccination with Myelin Oligodendrocyte Glycoprotein Reduces Stroke Size by Inducing IL-10-Producing CD4+ T Cells
J. Immunol.,
December 15, 2003;
171(12):
6549 - 6555.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Monsonego and H. L. Weiner
Immunotherapeutic Approaches to Alzheimer's Disease
Science,
October 31, 2003;
302(5646):
834 - 838.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Hauben, A. Gothilf, A. Cohen, O. Butovsky, U. Nevo, I. Smirnov, E. Yoles, S. Akselrod, and M. Schwartz
Vaccination with Dendritic Cells Pulsed with Peptides of Myelin Basic Protein Promotes Functional Recovery from Spinal Cord Injury
J. Neurosci.,
September 24, 2003;
23(25):
8808 - 8819.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bakalash, A. Kessler, T. Mizrahi, R. Nussenblatt, and M. Schwartz
Antigenic Specificity of Immunoprotective Therapeutic Vaccination for Glaucoma
Invest. Ophthalmol. Vis. Sci.,
August 1, 2003;
44(8):
3374 - 3381.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. N. Angelov, S. Waibel, O. Guntinas-Lichius, M. Lenzen, W. F. Neiss, T. L. Tomov, E. Yoles, J. Kipnis, H. Schori, A. Reuter, et al.
Therapeutic vaccine for acute and chronic motor neuron diseases: Implications for amyotrophic lateral sclerosis
PNAS,
April 15, 2003;
100(8):
4790 - 4795.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Schwartz
Neurodegeneration and Neuroprotection in Glaucoma: Development of a Therapeutic Neuroprotective Vaccine: The Friedenwald Lecture
Invest. Ophthalmol. Vis. Sci.,
April 1, 2003;
44(4):
1407 - 1411.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kipnis, T. Mizrahi, E. Hauben, I. Shaked, E. Shevach, and M. Schwartz
Neuroprotective autoimmunity: Naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system
PNAS,
November 26, 2002;
99(24):
15620 - 15625.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Mizrahi, E. Hauben, and M. Schwartz
The Tissue-Specific Self-Pathogen Is the Protective Self-Antigen: The Case of Uveitis
J. Immunol.,
November 15, 2002;
169(10):
5971 - 5977.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Kappos and P. Duda
The Janus face of CNS-directed autoimmune response: a therapeutic challenge
Brain,
November 1, 2002;
125(11):
2379 - 2380.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Schori, F. Lantner, I. Shachar, and M. Schwartz
Severe Immunodeficiency Has Opposite Effects on Neuronal Survival in Glutamate-Susceptible and -Resistant Mice: Adverse Effect of B Cells
J. Immunol.,
September 15, 2002;
169(6):
2861 - 2865.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bakalash, J. Kipnis, E. Yoles, and M. Schwartz
Resistance of Retinal Ganglion Cells to an Increase in Intraocular Pressure Is Immune-Dependent
Invest. Ophthalmol. Vis. Sci.,
August 1, 2002;
43(8):
2648 - 2653.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. B. Jones, D. M. Basso, A. Sodhi, J. Z. Pan, R. P. Hart, R. C. MacCallum, S. Lee, C. C. Whitacre, and P. G. Popovich
Pathological CNS Autoimmune Disease Triggered by Traumatic Spinal Cord Injury: Implications for Autoimmune Vaccine Therapy
J. Neurosci.,
April 1, 2002;
22(7):
2690 - 2700.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. P. Hofstetter, E. J. Schwarz, D. Hess, J. Widenfalk, A. El Manira, D. J. Prockop, and L. Olson
Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery
PNAS,
February 19, 2002;
99(4):
2199 - 2204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Hauben, A. Ibarra, T. Mizrahi, R. Barouch, E. Agranov, and M. Schwartz
Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: Comparison with other myelin antigens
PNAS,
December 18, 2001;
98(26):
15173 - 15178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kipnis, E. Yoles, H. Schori, E. Hauben, I. Shaked, and M. Schwartz
Neuronal Survival after CNS Insult Is Determined by a Genetically Encoded Autoimmune Response
J. Neurosci.,
July 1, 2001;
21(13):
4564 - 4571.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|